Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis.
about
Sphingosylphosphorylcholine in cancer progressStructure and mechanism of calmodulin binding to a signaling sphingolipid reveal new aspects of lipid-protein interactionsInflammation and skin cholesterol in LDLr-/-, apoA-I-/- mice: link between cholesterol homeostasis and self-tolerance?Neural processing of itch.Dissociation of calmodulin-target peptide complexes by the lipid mediator sphingosylphosphorylcholine: implications in calcium signaling.Hydrolysis of sphingosylphosphocholine by neutral sphingomyelinases.Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders.New advances on the functions of epidermal growth factor receptor and ceramides in skin cell differentiation, disorders and cancers.Epidermal sphingolipids: metabolism, function, and roles in skin disorders.Current evidence of skin barrier dysfunction in human and canine atopic dermatitis.Critical Role of the Sphingolipid Pathway in Stroke: a Review of Current Utility and Potential Therapeutic Targets.Glucosylsphingosine Activates Serotonin Receptor 2a and 2b: Implication of a Novel Itch Signaling Pathway.Simultaneous quantification of lyso-neutral glycosphingolipids and neutral glycosphingolipids by N-acetylation with [3H]acetic anhydride.Sphingosylphosphorylcholine is a Melanogenic Stimulator for Human Melanocytes.Reevaluation of the non-lesional dry skin in atopic dermatitis by acute barrier disruption: an abnormal permeability barrier homeostasis with defective processing to generate ceramide.
P2860
Q26778510-AE0A78AC-0602-44A6-83D8-6091F55FD5D6Q27662112-52EDDFFB-2CD6-4262-BE5A-A4A7643828CDQ28588533-0281203D-60B7-4DF6-A71E-52AB423D8FEAQ30428749-FBABB948-D808-4021-BB31-015C4B37F95AQ33581912-938C5F8C-66E3-4313-A153-0375431EDB64Q34292170-DE4A045F-125F-4F5C-B193-850CA6A084EDQ35324757-3195AB0B-17FB-42E3-B0A9-92578E259438Q35688961-7EF3C4B5-C7E9-40F9-B623-95AD74B8FF45Q35838744-57802109-10C3-4A85-ADAB-0844881B15D0Q36589543-53F3E1AE-6006-4C53-8C59-B9E62E7DB85DQ37854092-55EEC181-E292-4201-A12A-61733B3E95E1Q38875349-0F8BA681-8BEC-4B80-AB38-33AA44F8B07FQ41498409-800B2A36-A689-4329-AD57-F71CBBE79087Q44429382-C9A15E7A-0607-4964-80D9-3F816B4B7174Q44663190-024B28BC-8CAE-45D8-B7CF-1948C234CFC2Q52645660-ACEE586F-CCA7-45C0-86C9-A4F41DCB2EC5
P2860
Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Sphingosylphosphorylcholine is ...... tients with atopic dermatitis.
@en
Sphingosylphosphorylcholine is ...... tients with atopic dermatitis.
@nl
type
label
Sphingosylphosphorylcholine is ...... tients with atopic dermatitis.
@en
Sphingosylphosphorylcholine is ...... tients with atopic dermatitis.
@nl
prefLabel
Sphingosylphosphorylcholine is ...... tients with atopic dermatitis.
@en
Sphingosylphosphorylcholine is ...... tients with atopic dermatitis.
@nl
P2093
P2860
P1476
Sphingosylphosphorylcholine is ...... tients with atopic dermatitis.
@en
P2093
Genji Imokawa
Junko Arikawa
Makoto Kawashima
Mutsumi Ishibashi
Reiko Okamoto
Yutaka Takagi
P2860
P304
P356
10.1194/JLR.M200225-JLR200
P577
2003-01-01T00:00:00Z